Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$36K Sell
10,114
-22,352
-69% -$77.3K ﹤0.01% 3503
2025
Q4
$110K Buy
+32,466
New +$158K ﹤0.01% 2771
2025
Q2
Sell
-10,740
Closed -$58K 3160
2025
Q1
$58K Sell
10,740
-7,972
-43% -$45.2K ﹤0.01% 2227
2024
Q4
$92K Buy
+18,712
New +$98.1K ﹤0.01% 2047
2024
Q2
Sell
-73,457
Closed -$755K 2695
2024
Q1
$755K Buy
+73,457
New +$543K ﹤0.01% 1032
2021
Q3
Sell
-23,813
Closed -$280K 3540
2021
Q2
$280K Buy
+23,813
New +$274K ﹤0.01% 2186

Other funds holding LFMD

HRT Financial's LFMD Position: Q1 2026 in Review

HRT Financial reduced its LifeMD (LFMD) stake by 69% in Q1 2026, selling an estimated $77.3K and leaving 10,114 shares worth $36K. The position accounts for ﹤0.01% of the portfolio, ranked #3503.

HRT Financial first reported a position in LFMD in Q2 2021 and has held it in 6 quarters since. The position peaked at $755K in Q1 2024. 102 funds tracked by Wall St. Rank hold LFMD as of Q1 2026.

  • HRT Financial held 10,114 shares of LifeMD worth $36K as of Q1 2026.
  • HRT Financial sold 22,352 LifeMD shares in Q1 2026, an estimated $77.3K.
  • LifeMD made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3503 holding.
  • HRT Financial first reported a position in LifeMD in Q2 2021 and has held it in 6 quarters since.
  • HRT Financial's LifeMD position peaked at $755K in Q1 2024.
  • 102 funds tracked by Wall St. Rank held LifeMD as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.